Aytu BioPharma, Inc. Share Price & Technical Analysis
AYTU · $2.18 (-0.46%)
Healthcare / Drug Manufacturers - Specialty & Generic
$2.18
-0.46%
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release or…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-12% return in May, 4% avg return in past 3 year May month.
-8% return in 2026, -3% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 0% | 8% | -4% | -12% | – | – | – | – | – | – | – | -8% |
| 25 | 0% | -24% | -8% | 17% | 29% | 22% | 9% | -4% | -21% | 21% | 0% | 24% | 65% |
| 24 | -4% | 7% | 3% | -10% | 10% | -9% | -7% | -7% | -8% | -17% | -20% | 0% | -61% |
| 23 | -17% | -21% | -19% | 0% | -26% | -6% | 13% | -6% | 59% | 4% | -15% | 22% | -12% |
| 22 | -4% | -4% | -12% | -42% | -15% | 23% | -21% | -57% | -17% | -16% | 31% | -14% | -149% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$24.69M
P/E ratio
—
52W high
$3.07
52W low
$1.46
Volume
39,670
Beta
0.28
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Aytu BioPharma, Inc. share price today?
- Aytu BioPharma, Inc. (AYTU) last traded around $2.18 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does AYTU have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AYTU. Download the app for real-time alerts.
- How can I analyze Aytu BioPharma, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.